Join
Live feed
·
INSIDERFilingvia Quantisnow
Urovant Sciences Ltd. logo

SEC Form 4: M. James Hindman disposed to the issuer $0 worth of Common Shares (9,000 units at $0.00), decreasing direct ownership by 100% to 0 units

ByQuantisnow·Wall Street's wire, on your screen.
UROV· Urovant Sciences Ltd.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track UROV (Urovant Sciences Ltd.) and more on Quantisnow.